CG Oncology, Inc. Common stock

General ticker "CGON" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $3.6B (TTM average)

CG Oncology, Inc. Common stock follows the US Stock Market performance with the rate: 49.0%.

Estimated limits based on current volatility of 3.2%: low 68.66$, high 73.09$

Factors to consider:

  • Earnings expected soon, date: 2026-08-07 bmo
  • Total employees count: 142 (+25.7%) as of 2025
  • Top business risk factors: Single business dependence, Clinical trial failure, Regulatory and compliance, Inability to raise capital, Labor/talent shortage/retention
  • Current price 29.2% above estimated high
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [27.43$, 55.09$]
  • 2026-12-31 to 2027-12-31 estimated range: [21.29$, 44.87$]

Similar symbols

Short-term CGON quotes

Long-term CGON plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.20MM $1.14MM $4.04MM
Operating Expenses $55.65MM $115.81MM $194.81MM
Operating Income $-55.45MM $-114.67MM $-190.77MM
Non-Operating Income $6.84MM $26.63MM $29.78MM
R&D Expense $45.75MM $82.10MM $116.64MM
Income(Loss) $-48.61MM $-88.04MM $-161.00MM
Net Income(Loss)* $-48.61MM $-88.04MM $-161.00MM
Stockholders Equity $-123.10MM $733.38MM $752.60MM
Inventory $0.00MM $0.00MM $1.56MM
Assets $199.30MM $754.80MM $791.59MM
Operating Cash Flow $-45.68MM $-78.71MM $-132.35MM
Capital expenditure $0.00MM $0.23MM $0.13MM
Investing Cash Flow $-121.19MM $-300.76MM $-245.82MM
Financing Cash Flow $87.00MM $628.28MM $153.59MM
Earnings Per Share** $-0.73 $-1.41 $-2.08

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.